| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Biochemistry and Center in Molecular Toxicology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232 [J. L. C., P. B. I., M. J. M., F. P. G.], and CRC Molecular Toxicology Research Group, Middlesex School of Medicine, Cleveland St., London, W1P 6DB, United Kingdom [D. J. M., B. K.]
The major DNA adduct formed by the carcinogen ethylene dibromide (EDB) is S-[2-(N7-guanyl)ethyl]glutathione. This adduct results from the glutathione S-transferase (GST)-catalyzed conjugation of EDB with glutathione (GSH), which generates an episulfonium ion capable of reacting with cellular nucleophiles. Purified rat and human GST enzymes were compared for their ability to conjugate EDB with GSH and displayed high selectivity. Of the six forms of rat GST tested, conjugation was catalyzed by the
class enzyme 2-2 and, to a lesser extent, by the µ class enzyme 3-3. Of the three classes of cytosolic human GST, EDB conjugation was catalyzed by the
class enzymes. Three dimers of the human
class (
x-
x,
x-
y, and
y-
y) were separated by chromatofocusing. The
x-
x preparation demonstrated the highest specific activity. Rat microsomal GST had negligible activity for the conjugation of EDB with GSH. The levels of EDB-DNA adducts formed in rat and human hepatocytes were compared. DNA was isolated from both rat and human hepatocytes incubated with 0.5 mM EDB, and the level of DNA adduct formation in the human samples was about 40% of that in the rat hepatocytes. EDB concentration-dependent unscheduled DNA synthesis was demonstrated in isolated human hepatocytes. Concurrent treatment of the hepatocytes with diethylmaleate to deplete intracellular GSH inhibited EDB-induced unscheduled DNA synthesis. These results indicate that EDB alkylates DNA in human hepatocytes and that enzymatic repair of adducts may occur. The results of experiments done in rat and human systems using both purified GST enzymes and intact hepatocytes imply that the genotoxic pathway of EDB metabolism in rats and humans is similar.
1 Supported in part by USPHS Grants CA 44353, ES 00267, ES 01590, and ES 03272.
2 Present address: Pfizer Central Research, Drug Metabolism Department, Eastern Point Rd., Groton, CT 06340.
3 Present address: Department of Biochemistry, School of Dentistry, Oregon Health Sciences University, Portland, OR 97201.
4 To whom requests for reprints should be addressed.
Received 9/ 7/89.
Revised 2/ 1/90.
This article has been cited by other articles:
![]() |
S. Kurtovic, A. Shokeer, and B. Mannervik Diverging catalytic capacities and selectivity profiles with haloalkane substrates of chimeric alpha class glutathione transferases Protein Eng. Des. Sel., May 1, 2008; 21(5): 329 - 341. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Tornero-Velez, M. K. Ross, C. Granville, J. Laskey, J. P. Jones, D. M. DeMarini, and M. V. Evans METABOLISM AND MUTAGENICITY OF SOURCE WATER CONTAMINANTS 1,3-DICHLOROPROPANE AND 2,2-DICHLOROPROPANE Drug Metab. Dispos., January 1, 2004; 32(1): 123 - 131. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. W. Wormhoudt, A. M. Hissink, J. N. M. Commandeur, P. J. van Bladeren, and N. P. E. Vermeulen Disposition of 1,2-[14C]Dibromoethane in Male Wistar Rats Drug Metab. Dispos., May 1, 1998; 26(5): 437 - 447. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |